Standard
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. / Pascoe, Steven; Barnes, Neil; Brusselle, Guy; Compton, Chris; Criner, Gerard J.; Dransfield, Mark T.; Halpin, David M. G.; Han, MeiLan K.; Hartley, Benjamin; Lange, Peter; Lettis, Sally; Lipson, David A.; Lomas, David A.; Martinez, Fernando J.; Papi, Alberto; Roche, Nicolas; van der Valk, Ralf J. P.; Wise, Robert; Singh, Dave.
In:
The Lancet Respiratory Medicine, Vol. 7, No. 9, 2019, p. 745-756.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Pascoe, S, Barnes, N, Brusselle, G, Compton, C, Criner, GJ, Dransfield, MT, Halpin, DMG, Han, MK, Hartley, B
, Lange, P, Lettis, S, Lipson, DA, Lomas, DA, Martinez, FJ, Papi, A, Roche, N, van der Valk, RJP, Wise, R & Singh, D 2019, '
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial',
The Lancet Respiratory Medicine, vol. 7, no. 9, pp. 745-756.
https://doi.org/10.1016/S2213-2600(19)30190-0APA
Pascoe, S., Barnes, N., Brusselle, G., Compton, C., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Hartley, B.
, Lange, P., Lettis, S., Lipson, D. A., Lomas, D. A., Martinez, F. J., Papi, A., Roche, N., van der Valk, R. J. P., Wise, R., & Singh, D. (2019).
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
The Lancet Respiratory Medicine,
7(9), 745-756.
https://doi.org/10.1016/S2213-2600(19)30190-0Vancouver
Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT et al.
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
The Lancet Respiratory Medicine. 2019;7(9):745-756.
https://doi.org/10.1016/S2213-2600(19)30190-0Author
Pascoe, Steven ; Barnes, Neil ; Brusselle, Guy ; Compton, Chris ; Criner, Gerard J. ; Dransfield, Mark T. ; Halpin, David M. G. ; Han, MeiLan K. ; Hartley, Benjamin ; Lange, Peter ; Lettis, Sally ; Lipson, David A. ; Lomas, David A. ; Martinez, Fernando J. ; Papi, Alberto ; Roche, Nicolas ; van der Valk, Ralf J. P. ; Wise, Robert ; Singh, Dave. / Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. In: The Lancet Respiratory Medicine. 2019 ; Vol. 7, No. 9. pp. 745-756.
Bibtex
@article{fb39b6a5d5164ab49ebf2b7548526bfe,
title = "Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial",
author = "Steven Pascoe and Neil Barnes and Guy Brusselle and Chris Compton and Criner, {Gerard J.} and Dransfield, {Mark T.} and Halpin, {David M. G.} and Han, {MeiLan K.} and Benjamin Hartley and Peter Lange and Sally Lettis and Lipson, {David A.} and Lomas, {David A.} and Martinez, {Fernando J.} and Alberto Papi and Nicolas Roche and {van der Valk}, {Ralf J. P.} and Robert Wise and Dave Singh",
year = "2019",
doi = "10.1016/S2213-2600(19)30190-0",
language = "English",
volume = "7",
pages = "745--756",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "The Lancet Publishing Group",
number = "9",
}
RIS
TY - JOUR
T1 - Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
AU - Pascoe, Steven
AU - Barnes, Neil
AU - Brusselle, Guy
AU - Compton, Chris
AU - Criner, Gerard J.
AU - Dransfield, Mark T.
AU - Halpin, David M. G.
AU - Han, MeiLan K.
AU - Hartley, Benjamin
AU - Lange, Peter
AU - Lettis, Sally
AU - Lipson, David A.
AU - Lomas, David A.
AU - Martinez, Fernando J.
AU - Papi, Alberto
AU - Roche, Nicolas
AU - van der Valk, Ralf J. P.
AU - Wise, Robert
AU - Singh, Dave
PY - 2019
Y1 - 2019
U2 - 10.1016/S2213-2600(19)30190-0
DO - 10.1016/S2213-2600(19)30190-0
M3 - Journal article
VL - 7
SP - 745
EP - 756
JO - The Lancet Respiratory Medicine
JF - The Lancet Respiratory Medicine
SN - 2213-2600
IS - 9
ER -
